MedTrace Logo

VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up （VITAL）

NCT05977257 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2023-08-04

No results posted yet for this study

Summary

This study is an observational study to evaluate the long-term safety and effectiveness of the valve system.

Conditions

  • Aortic Valve Disease
  • Aortic Valve Stenosis

Interventions

DEVICE

VitaFlow® Transcatheter Aortic Valve Replacement System

This study is an observational study, for who have joined the VitaFlow® Catheter Aortic Valve System pre-market trial

Sponsors & Collaborators

  • Shanghai MicroPort CardioFlow Medtech Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Daxin Zhou · Fudan University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-30
Primary Completion
2025-10-30
Completion
2028-10-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05977257 on ClinicalTrials.gov